AMRX

AcronymDefinition
AMRXApplied Mathematics Research Express (journal)
References in periodicals archive ?
(NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
Amneal Pharmaceuticals Inc (NYSE: AMRX), a specialty pharmaceutical company, announced yesterday a 10-year license and supply contract with Jerome Stevens Pharmaceuticals Inc, a New York-based pharmaceutical manufacturer of prescription tablet and capsule formulations, effective 22 March 2019.
Piper Jaffray analyst David Amsellem upgraded Amneal Pharmaceuticals (AMRX) to Overweight from Neutral with an unchanged price target of $11.
- Bridgewater, New Jersey-based integrated specialty pharmaceutical company Amneal Pharmaceuticals (NYSE: AMRX) has received US Food and Drug Administration approval on its abbreviated new drug application for cyclophosphamide for injection, the therapeutic equivalent to Cytoxan, the company said.
Amneal Pharmaceuticals (AMRX) increased the price of a three-month supply of Unithroid, a thyroid medication, by about 10%, according to the report.
The complaint alleges that Teva, Novartis' (NVS) Sandoz, Mylan (MYL), Pfizer (PFE) and 16 other generic drug manufacturers, including Amneal Pharmaceuticals (AMRX), Dr.
Shares in Impax (IPXL) withdrew trading on the NASDAQ stock exchange on 4 May this year and Amneal commences trading on the New York Stock Exchange under the ticker 'AMRX'.
RBC Capital analyst Randall Stanicky is positive on Amneal Pharmaceuticals (AMRX), Endo International (ENDP), Flexion Therapeutics (FLXN), Jazz Pharmaceuticals (JAZZ) as his top selections in Specialty Pharma, saying the sector has come under particular pressure in the most recent market sell-off.
On 4 May 2018, the shares of Impax (IPXL) are expected to cease trading on the NASDAQ stock exchange and the new combined company, Amneal Pharmaceuticals Inc (the Company), will begin trading on the New York Stock Exchange (NYSE) under the ticker "AMRX" on 7 May 2018.
Lannett (LCI), up 5% after entering into an exclusive agreement with Amneal Pharmaceuticals (AMRX) for Levothyroxine sodium tablets...
Amneal Pharmaceuticals (AMRX) downgraded to Hold from Buy at SunTrust with analyst John Boris saying while the company has indicated that it has the highest number of approvals on tap for FY19, its Q4 is faced with pressure from the earlier than anticipated timing from top drug competition.
Leerink analyst Ami Fadia tells investors in a research note that she is "incrementally positive" on the state of the generics industry following investor meetings with the management teams from Outperform-rated Amneal (AMRX), Pfenex and Teligent.